PF-07868489

N/A

Report date: 2026/05/13 20:02:10

Base Information

Drug NamePF-07868489
Drug Alias NamePF-07868489
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Growth/differentiation factor 2
TargetsGrowth/differentiation factor 2
Therapy Area/IndicationsPulmonary Arterial HypertensionHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[14] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer (China) Research And Development Co LtdPfizer IncWyeth BioPharma Division of Wyeth Pharmaceuticals Llc +[4] 
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial HypertensionHypertension, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A